Alector, Inc.

Stocks

ALEC

US0144421072

Market Closed - Nasdaq Other stock markets 16:00:00 2026-08-07 EDT			5-day change	1st Jan Change
1.780 ^USD	-2.73%		+17.88%	+14.10%

08-06	Alector, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-09	Wall Street Ignores the Sirens

Transcript : Alector, Inc. - Special Call

Published on 05/05/2026 at 10:37 am EDT - Modified on 06/12/2026 at 12:03 pm EDT

S&P Capital IQ

Presenter Speech
Pete Stavropoulos (Analysts)

Hello, everyone. I'm Pete Stavropoulos, biotech analyst at Cantor with another webinar on the blood-brain barrier crossing technologies. It's an exciting

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Full unlimited browsing across the entire site

Access to all the news and all the data

Access to US, EUROPE AND ASIA Portfolios

Zero Ads for a completely uninterrupted reading experience

Pro Tools: Expert insights, Expert Screeners, historical financial data and reports, thematic lists, transcripts...

Latest news about Alector, Inc.

08-06	Alector, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-09	Wall Street Ignores the Sirens
07-09	GSK adds Royal Philips' Chief Executive Jakobs to board	AN
07-09	Oil keeps markets on edge
07-09	UK Stocks-Factors to watch on July 9	RE
07-08	Alector and GSK partnership to end after dementia, Alzheimer's drug failures	RE
07-08	Alector, Inc. Announces Termination of Collaboration Agreement with Glaxo Wellcome UK Limited	CI
07-08	Alector LLC and Alector, Inc. Repay $10,428,827.77 Aggregate Principal Amount Of Loans Under Loan And Security Agreement With Hercules Capital, Inc	CI
05-07	Alector, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-05	Alector, Inc. - Special Call
04-29	Alector to discontinue phase 2 trial of nivisnebart	RE
04-29	Alector Inc Discontinues Phase 2 Progress-Ad Trial of Nivisnebart and Provides Pipeline Update	CI
04-15	Alector Shares Rise After Cantor Fitzgerald Upgrade	MT
04-15	Cantor Fitzgerald Upgrades Alector to Overweight From Neutral	MT
03-12	Alector Files $400 Million Mixed Shelf	MT